Exploring efficient and effective mammalian models for Alzheimer’s disease

Exploring efficient and effective mammalian models for Alzheimer’s disease

The aim of this study was to explore and discuss efficient and effective mammalian models for Alzheimer’s disease (AD). In this study, efficient AD models are characterized by a small body size, a short lifespan, and rapid development of the main pathology including amyloid plaque formation. Effecti...

Full description

Saved in:

Bibliographic Details
Main Author:	Mitsunori Kayano
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Aging Neuroscience
Subjects:	amyloid-β α-synuclein blood brain barrier cerebral amyloid angiopathy marmoset dog
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2025.1652754/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of neuroinflammation in cerebral amyloid angiopathy
by: Hilde van den Brink, et al.
Published: (2024-12-01)

Unraveling the complex role of microglia in Alzheimer’s disease: amyloid β metabolism and plaque formation
by: Sho Takatori, et al.
Published: (2025-05-01)

Cross-sectional and longitudinal quantification of total white matter perivascular space volume fraction in Dutch-type Cerebral Amyloid Angiopathy
by: Manon R. Schipper, et al.
Published: (2025-01-01)

Cerebral Amyloid Angiopathy Related Inflammation: A Single-Center Case Series Analysis
by: Syed Zahid Ali, et al.
Published: (2025-04-01)

The Role of CSF Biomarkers in Discriminating Between Cerebral Amyloid Angiopathy and Alzheimer’s Disease Patients: Systematic Review of Clinical Studies
by: Zahra Razmkhah, et al.
Published: (2024-10-01)

Optical Taxonomic Signal and the Diagnosis of Alzheimer's Disease
by: Frank A. Greco, et al.
Published: (2025-01-01)

Engineered nanoparticles for the treatment of Alzheimer’s disease
by: Jia Jia, et al.
Published: (2025-04-01)

Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature review
by: Charlotte Jacob, et al.
Published: (2025-01-01)

Mouse models of Anti-Aβ immunotherapies
by: Philip Pikus, et al.
Published: (2025-05-01)

Neuropathological Correlates of White Matter Hyperintensities in Cerebral Amyloid Angiopathy
by: Nazanin Makkinejad, et al.
Published: (2024-11-01)

Cerebrospinal Fluid Aβ Biomarkers Predict Recurrent Hemorrhage and Identify Cerebral Amyloid Angiopathy in Patients With Lobar Hemorrhage
by: Philipp Arndt, et al.
Published: (2025-08-01)

Exploration of common pathogenic genes between cerebral amyloid angiopathy and insomnia based on bioinformatics and experimental validation
by: Xin-Yu Li, et al.
Published: (2025-07-01)

Modulation of Rage and CD147 in Cerebral Amyloid Angiopathy <i>in vitro</i>
by: A. I. Mosiagina, et al.
Published: (2022-05-01)

Cerebral inflammatory amyloid angiopathy: response to treatment
by: João Roberto Ribeiro Pimenta, et al.
Published: (2025-08-01)

A manifesto for Alzheimer’s disease drug discovery in the era of disease-modifying therapies
by: Heike Hering, et al.
Published: (2025-08-01)

Proportions of Basement Membrane Proteins in Cerebrovascular Smooth Muscle Cells After Exposure to Hypercapnia and Amyloid Beta
by: Jennifer M. Dewing, et al.
Published: (2025-04-01)

Positron Emission Tomography in Cerebral Amyloid Angiopathy: A Scoping Review
by: Marialuisa Zedde, et al.
Published: (2025-04-01)

Cerebral hemorrhage due to amyloid angiopathy that was difficult to differentiate from breast cancer metastasis: a case report
by: Toshitaka Uomori, et al.
Published: (2021-06-01)

Autophagy in alzheimer disease pathogenesis and its therapeutic values
by: Gabrielle Angst, et al.
Published: (2025-12-01)

Increased Plasma β‐Secretase 1 Activity Correlates With Neurodegeneration in Cerebral Small Vessel Disease
by: Ya Su, et al.
Published: (2024-12-01)

Reduction of orexin-expressing neurons and a unique sleep phenotype in the Tg-SwDI mouse model of Alzheimer’s disease
by: Yan Wu, et al.
Published: (2025-02-01)

Computational discovery of plant-derived flavonoids as potential amyloid-β fibril disaggregating agents for alzheimer’s disease
by: Uthirapathi Logeswari Rakesh, et al.
Published: (2025-06-01)

Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy‐confirmed cohort from China
by: Xiang‐Sha Yin, et al.
Published: (2025-04-01)

Cerebral Amyloid Angiopathy Is Associated With Higher R2 Relaxation Rate: An MRI and Pathology Study
by: Md Tahmid Yasar, et al.
Published: (2025-06-01)

Neuroradiological Findings in Cerebral Amyloid Angiopathy with a Particular Consideration of the Boston Criteria 2.0: An Imaging Review
by: Ulf Jensen-Kondering, et al.
Published: (2024-11-01)

Iatrogenic Dementia: Providing Insight into Transmissible Subtype of Alzheimer’s Disease, Creutzfeldt–Jakob Disease and Cerebral Amyloid Angiopathy
by: Stella Karatzetzou, et al.
Published: (2025-04-01)

Study on the Therapeutic Effects of Bisdemethoxycurcumin on a Cerebral Amyloid Angiopathy Mouse Model Established via Chronic Treatment With Five Vascular Risk Factors
by: Shudong Lin, et al.
Published: (2025-01-01)

Diagnosis, pathomechanisms and therapy of cerebral amyloid angiopathy-related inflammation (CAA-ri)
by: Rebecca M. Seifert, et al.
Published: (2025-04-01)

Enhanced Blood‐Brain Barrier Penetrability of BACE1 SiRNA‐Loaded Prussian Blue Nanocomplexes for Alzheimer's Disease Synergy Therapy
by: Xiaoyuan Ding, et al.
Published: (2025-08-01)

Convexity subarachnoid hemorrhage: clinical features and etiology of an Argentinian cohort
by: Aníbal Chertcoff, et al.

Iatrogenic Cerebral Amyloid Angiopathy After Childhood Brain Surgery: Novel Findings of MRI and CT
by: Fumine Tanaka, et al.
Published: (2025-04-01)

Kisspeptin is elevated in the brain after intracerebral haemorrhagic stroke
by: Saumya Maheshwari, et al.
Published: (2024-12-01)

Traumatic Brain Injury and Chronic Traumatic Encephalopathy: Not Only Trigger for Neurodegeneration but Also for Cerebral Amyloid Angiopathy?
by: Marialuisa Zedde, et al.
Published: (2025-04-01)

A de novo, mosaic and complex chromosome 21 rearrangement causes APP triplication and familial autosomal dominant early onset Alzheimer disease
by: Emma Ehn, et al.
Published: (2025-01-01)

Research progress on cerebral small vessel disease in 2024
by: YI Haotong, MEN Xuejiao, QIN Bing, WEI Lei, CAI Wei, LU Zhengqi
Published: (2025-03-01)

Cerebral Amyloid Angiopathy: Clinical Presentation, Sequelae and Neuroimaging Features—An Update
by: Stefan Weidauer, et al.
Published: (2025-03-01)

Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein
by: Jingfeng Liang, et al.
Published: (2025-08-01)

Human iPSC-derived pericyte-like cells carrying APP Swedish mutation overproduce beta-amyloid and induce cerebral amyloid angiopathy-like changes
by: Ying-Chieh Wu, et al.
Published: (2024-09-01)

Apolipoprotein E genotype is associated with island sign in lobar intracerebral hemorrhage
by: Qiong Yang, et al.
Published: (2025-02-01)

Long-term follow-up of retinal amyloid angiopathy in a large Chinese family with hereditary amyloid transthyretin
by: Jiangning Xu, et al.
Published: (2025-04-01)